GPX3 suppresses lung adenocarcinoma progression through HSPB1 ubiquitination and Hippo pathway activation
Cell Reports · 2026
DOI: 10.1016/j.celrep.2026.117923 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026. Verfasst von Sixuan Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, China; Department of Oncology, The First Affiliated Hos…. Hauptthemen laut MEDLINE: Lung Neoplasms, Adenocarcinoma of Lung, Glutathione Peroxidase, Protein Serine-Threonine Kinases. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fujian Provincial Natural Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, China; Department of Oncology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 42…
- Endoscopy Center, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
- Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, China.
- Interdisciplinary Institute of Medical Engineering of Fuzhou University, Fuzhou 350108, China.
- Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, China; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou…
- Department of Oncology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 421001, China. Electronic address: liyuehua2020@stu.usc.edu.cn.
Förderung
- Fujian Provincial Natural Science Foundation
Zitieren
APA
Wu, S., Huang, H., Pan, J., Zheng, Y., Pan, Q., Chen, S., Zhang, J., Li, Y., & Xu, Y. (2026). GPX3 suppresses lung adenocarcinoma progression through HSPB1 ubiquitination and Hippo pathway activation. Cell Reports. https://doi.org/10.1016/j.celrep.2026.117923
Vancouver
Wu S, Huang H, Pan J, Zheng Y, Pan Q, Chen S, et al. GPX3 suppresses lung adenocarcinoma progression through HSPB1 ubiquitination and Hippo pathway activation. Cell Reports. 2026. doi:10.1016/j.celrep.2026.117923
BibTeX
@article{Wu2026,
author = {Wu, Sixuan and Huang, He and Pan, Junfan and Zheng, Yaqin and Pan, Qihong and Chen, Sihui and Zhang, Jing and Li, Yuehua and Xu, Yiquan},
title = {GPX3 suppresses lung adenocarcinoma progression through HSPB1 ubiquitination and Hippo pathway activation},
journal = {Cell Reports},
year = {2026},
doi = {10.1016/j.celrep.2026.117923}
}
EUVIMED